Faisal Ghiath Sukhtian bought $100K of OTLK stock

Faisal Ghiath Sukhtian, Dir of Outlook Therapeutics, Inc. (OTLK), bought 95,398 shares of OTLK stock worth $100K, per an SEC Form 4 filed Jul 29, 2026.

It was an open-market purchase.

The trade was reported on Jul 29, 2026.

OTLK has moved -58.7% since the trade date, from $1.00 to $0.41 (Nov 13, 2026 close).